Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Turkey / NCT06307886
Recruiting Observational

Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator

NCT06307886 · tracked via the Priya Life Science Turkey tracker
Sponsor
Gaziosmanpasa Research and Education Hospital
Phase
Observational
Started
2023-09-01
Last updated
2025-01-07

Condition(s) studied

Endometrial Cancer

Investigational drug(s) / intervention(s)

Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With manipulatorlPatients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy without uterine manipulator

Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With manipulator: patients who underwent laparoscopic hysterectomy with using uterine manipulator

lPatients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy without uterine manipulator: patients who underwent laparoscopic hysterectomy without using uterine manipulator

Study summary

Comparison of five-year survival and disease-free survival in patients diagnosed with endometrium cancer who underwent total laparoscopic hysterectomy with and without a uterine manipulator

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: * patients suitable for laparoscopic surgery patients ages 18-75 patients diagnosed figo stage 1 and 2 endometrial cancer Exclusion Criteria: * patients not suitable for laparoscopic surgery patients diagnosed figo stage 3 and 4 endometrial cancer pregnant patients

Primary outcome measure(s)

  • five year survival in patients diagnosed with endometrial cancer — 5 year
  • disease-free survival in patients diagnosed with endometrial cancer — 5 year

Trial sites (1)

FacilityCityRegionStatus
Gaziosmanpasa Training and research hospital Istanbul Turkey (Türkiye) Recruiting

More Gaziosmanpasa Research and Education Hospital trials in Turkey

VNOTES Approach in Mesh Free Sacrocolpopexy: A Functional and Anatomic Evaluation Recruiting
The Effect of Peloidotherapy in Young Adults Undergoing Physical Therapy Scoliosis Specific Exercises (PSSE) Recruiting
Hemodynamic Effects of Surgical Position in Prone vs. Supine Percutaneous Nephrolithotomy Recruiting
Timing of LNG-IUD Insertion and Ovarian Cyst Formation Recruiting
Thyroid-Stimulating Hormone Levels in Pregnancy and Their Association With Depression, Anxiety, and Sexual Function Recruiting

Other trials for the same condition

Low-Residue Diet Versus Rectal Enema Before Laparoscopic Surgery for Endometrial Cancer Recruiting
27-Inch Versus 55-Inch Monitors in Women Undergoing Endometrial Cancer Surgery Starting soon
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Recruiting
The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer Recruiting
Comparison of Sentinel Lymph Node Applications in Endometrial Cancer Cases Performed With Vaginal Natural Orifice Transluminal Endoscopic Surgery (V-NOTES) and Conventional Laparoscopy Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06307886 on ClinicalTrials.gov ↗ ← All trials in Turkey